9164 Federal Register / Vol. 89, No. 28 / Friday, February 9, 2024 / Notices 

Service Act (42 U.S.C. 300aa–1), the 

Secretary of HHS was mandated to 

establish the National Vaccine Program 

to achieve optimal prevention of human 

infectious diseases through 

immunization and to achieve optimal 

prevention against adverse reactions to 

vaccines. The NVAC was established to 

provide advice and make 

recommendations to the Director of the 

National Vaccine Program on matters 

related to the Program’s responsibilities. 

The Assistant Secretary for Health 

serves as Director of the National 

Vaccine Program. 

During this meeting, NVAC will hear 

presentations to support the recent 

charge on innovation from Admiral 

Rachel L. Levine, MD, the Assistant 

Secretary for Health and Director of the 

National Vaccine Program. NVAC will 

also hear presentations on recent surges 

in measles cases, the Vaccines for 

Children’s Program, real uses of 

artificial intelligence to support 

vaccination efforts, and supply chains. 

Presenters will also cover ways to 

improve immunization of children, 

adults, and pregnant people. Please note 

that agenda items are subject to change, 

as priorities dictate. Information on the 

final meeting agenda will be posted 

prior to the meeting on the NVAC 

website: http://www.hhs.gov/nvpo/ 

nvac/index.html. 

Members of the public will have the 

opportunity to provide comment at the 

NVAC meeting during the public 

comment period designated on the 

agenda. Public comments made during 

the meeting will be limited to three 

minutes per person to ensure time is 

allotted for all those wishing to speak. 

Members of the public may also submit 

written comments. Written comments 

should not exceed three pages in length. 

Individuals planning to submit 

comments should email their written 

comments or their request to provide a 

comment during the meeting to nvac@

hhs.gov at least five business days prior 

to the meeting. 

Dated: January 11, 2024. 

Ann Aikin, 

Acting Designated Federal Official, Office of 

the Assistant Secretary for Health. 

[FR Doc. 2024–02636 Filed 2–8–24; 8:45 am] 

BILLING CODE 4150–44–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Closed Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Initial Review Group; Digestive Diseases and 

Nutrition C Study Section Digestive Diseases 

and Nutrition C Study Section. 

Date: March 13–15, 2024. 

Time: 5:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, NIDDK 

Democracy II, Suite 7000A, 6707 Democracy 

Boulevard, Bethesda, MD 20892 (Virtual 

Meeting). 

Contact Person: Peter J. Kozel, Ph.D., 

Scientific Review Officer, NIDDK/Scientific 

Review Branch, National Institutes of Health, 

6707 Democracy Blvd., Room 7009, 

Bethesda, MD 20892, (301) 594–4721, 

kozelp@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 

Dated: February 6, 2024. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–02697 Filed 2–8–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Advancing 

Translational Sciences; Notice of 

Closed Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Center for 

Advancing Translational Sciences Special 

Emphasis Panel; Understudied Proteins 

Associated with Rare Diseases (R03) Review. 

Date: May 30, 2024. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Center for Advancing 

Translational Sciences, National Institutes of 

Health, 6701 Democracy Boulevard, 

Bethesda, MD 20892. 

Contact Person: Ming Yan, MD, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, Division of Extramural Activities, 

National Center for Advancing Translational 

Sciences, National Institutes of Health, 6701 

Democracy Boulevard, MSC 4874, Bethesda, 

MD 20892, (301) 827–4312, ming.yan@

nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.859, Pharmacology, 

Physiology, and Biological Chemistry 

Research; 93.350, B—Cooperative 

Agreements; 93.859, Biomedical Research 

and Research Training, National Institutes of 

Health, HHS) 

Dated: February 5, 2024. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–02651 Filed 2–8–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Mental Health; 

Amended Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the National Institute of 

Mental Health Special Emphasis Panel 

BRAIN K99, March 6, 2024, 11:00 a.m. 

to March 06, 2024, 6:30 p.m., National 

Institutes of Health, Neuroscience 

Center, 6001 Executive Boulevard, 

Rockville, MD 20852 which was 

published in the Federal Register on 

February 2, 2024, FR Doc. 2024–02045, 

89 FR 7403. 

The meeting date has changed from 

March 6, 2024, to March 15, 2024. The 


ddrumheller on DSK120RN23PROD with NOTICES1